Glioblastoma Multiforme Research Solutions

Date Published:

Watch our video to learn how our digital solutions and clinical science expertise can advance the development of new therapeutic options for glioblastoma multiforme (GBM) by helping to:

  • Integrate patient quality-of-life and functional status measures to accurately assess the impact of disease and treatment symptoms
  • Convey protocol requirements concisely so study teams can capture truly informed consent
  • Train and monitor raters to administer/score assessments accurately and consistently
  • Manage complex randomization, multiple treatment arms and cohorts, and variable dosing schemes common in oncology trials